Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,044 | -21,195 | -9,660 | -40,855 | -21,717 |
| Depreciation Amortization | 435 | 262 | 136 | 233 | 110 |
| Accounts payable and accrued liabilities | 4,147 | 3,196 | 853 | -90 | 728 |
| Other Working Capital | -600 | -1,987 | -5,805 | 4,475 | -577 |
| Other Operating Activity | 2,883 | 1,721 | 1,288 | 10,527 | 3,275 |
| Operating Cash Flow | $-25,179 | $-18,003 | $-13,189 | $-25,710 | $-18,181 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,000 | 25,000 |
| Debt Repayment | -46 | -33 | -21 | N/A | N/A |
| Common Stock Issued | 5,656 | 4,841 | 4,589 | 10,008 | 30 |
| Other Financing Activity | 0 | 0 | 0 | -720 | -449 |
| Financing Cash Flow | $5,610 | $4,808 | $4,568 | $34,287 | $24,581 |
| Beginning Cash Position | 73,820 | 73,820 | 73,820 | 65,243 | 65,243 |
| End Cash Position | 54,251 | 60,625 | 65,199 | 73,820 | 71,642 |
| Net Cash Flow | $-19,569 | $-13,195 | $-8,621 | $8,578 | $6,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,179 | -18,003 | -13,189 | -25,710 | -18,181 |
| Free Cash Flow | -25,179 | -18,003 | -13,189 | -25,710 | -18,181 |